Acquisition of BTK C481S Produces Resistance to Ibrutinib in MYD88 Mutated WM and ABC DLBCL Cells That Is Accompanied By ERK1/2 Hyperactivation, and Is Targeted By the Addition of the ERK1/2 Inhibitor Ulixertinib
暂无分享,去创建一个
S. Treon | Z. Hunter | J. Castillo | Guang Yang | Lian Xu | C. Patterson | Xia Liu | Jiaji G. Chen | M. Demos | N. Tsakmaklis | Jie Chen